FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
New non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
Hosted on MSN21h
Can FDA-approved Journavx Put An End To Death From Opioids?
This approval is considered a major breakthrough in treating acute pain without the need for opioid medication as reliance on ...
fingerlakes16h
FDA approves non-addictive alternative to opioids: How does it work?
The FDA has approved Vertex Pharmaceuticals’ Journavx, a new pain medication designed to reduce the risk of addiction and overdose associated with opioids. Intended for short-term pain after surgeries ...
Daily Jang10h
FDA approves first novel non-opioid painkiller in decades
The US Food and Drug Administration has approved the first-ever non-opioid pain reliever in more than two decades.According ...
FDA approves new non-addictive painkiller alternative to opioids
The drug is called Journavx and doctors believe it has no potential for addiction and dependence.
Daijiworld21h
US FDA approves painkillers designed to eliminate risk of addiction associated with opioids
US federal officials have approved a new type of pain pill designed to eliminate the risks of addiction and overdose associated with opioid medications like Vicodin and OxyContin. The US Food and Drug ...
KAAL TV21h
FDA approves new pain medication intended to reduce likelihood of addiction
The Food and Drug Administration has approved a first of its kind prescription pain medication that is non-opioid.
Vertex Pharmaceuticals price target raised to $433 from $430 at Scotiabank
Scotiabank raised the firm’s price target on Vertex Pharmaceuticals (VRTX) to $433 from $430 and keeps a Sector Perform rating on the shares. Vertex’s suzetrigine, branded Journavx, was recently ...
The Street Journal7h
US health agency approves brand-new painkiller
A new type of painkiller aimed at treating pain from an injury or surgery has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, also known by its brand name Journavx, ...
Pharmabiz18h
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain
Vertex Pharmaceuticals’ suzetrigine gets US FDA approval for treatment of adults with moderate-to-severe acute pain: Boston Saturday, February 1, 2025, 14:00 Hrs [IST] Vertex Ph ...